- 0人关注
g&c vi limited
股票筛选 · · · · · ·
| g&c vi limited十大流通股股票 | g&c vi limited十大股东股票 |
| 序号 | 股票 | 持股数量(万股) | 股价 | 至今涨幅 | 股份性质 | 占总股本比例 | 持股变动 | 总市值 | 报告期 |
| 1 | 药明康德603259历史分时日K | 14301.58 | 46.18 | 境外法人股 | 4.876% | 未变 | 2024-03-31 | ||
| 2 | 药明康德603259历史分时日K | 14301.58 | 境外法人股 | 4.842% | 增持 | 2024-03-08 | |||
| 3 | 药明康德603259历史分时日K | 14300 | 流通A股 | 4.84% | 减持 | 2024-02-01 | |||
| 4 | 药明康德603259历史分时日K | 14301.58 | 72.76 | 境外法人股 | 4.818% | 未变 | 2023-12-31 | ||
| 5 | 药明康德603259历史分时日K | 14301.58 | 86.18 | 境外法人股 | 4.818% | 减持 | 2023-09-30 | ||
| 6 | 药明康德603259历史分时日K | 15292.36 | 62.31 | 境外法人股 | 5.162% | 减持 | 2023-06-30 | ||
| 7 | 药明康德603259历史分时日K | 16171.83 | 79.50 | 境外法人股 | 5.461% | 减持 | 2023-03-31 | ||
| 8 | 药明康德603259历史分时日K | 17664.35 | 81.00 | 境外法人股 | 5.98% | 减持 | 2022-12-31 | ||
| 9 | 药明康德603259历史分时日K | 18305.89 | 71.69 | 境外法人股 | 6.197% | 减持 | 2022-09-30 | ||
| 10 | 药明康德603259历史分时日K | 19051.2 | 103.99 | 境外法人股 | 6.47% | 未变 | 2022-06-30 | ||
| 11 | 药明康德603259历史分时日K | 19051.2 | 112.38 | 境外法人股 | 6.481% | 未变 | 2022-03-31 | ||
| 12 | 药明康德603259历史分时日K | 19051.2 | 118.58 | 境外法人股 | 6.482% | 未变 | 2021-12-31 | ||
| 13 | 药明康德603259历史分时日K | 19051.2 | 152.80 | 境外法人股 | 6.489% | 未变 | 2021-09-30 | ||
| 14 | 药明康德603259历史分时日K | 19051.2 | 156.59 | 境外法人股 | 6.517% | 新进 | 2021-06-30 |
| 序号 | 股票 | 持股数量(万股) | 股价 | 至今涨幅 | 股份性质 | 占总股本比例 | 持股变动 | 总市值 | 报告期 |
| 1 | 药明康德603259历史分时日K | 14301.58 | 46.18 | 流通A股 | 4.88% | 未变 | 2024-03-31 | ||
| 2 | 药明康德603259历史分时日K | 14301.58 | 流通A股 | 4.84% | 增持 | 2024-03-08 | |||
| 3 | 药明康德603259历史分时日K | 14300 | 流通A股 | 4.84% | 减持 | 2024-02-01 | |||
| 4 | 药明康德603259历史分时日K | 14301.58 | 72.76 | 流通A股 | 4.82% | 未变 | 2023-12-31 | ||
| 5 | 药明康德603259历史分时日K | 14301.58 | 86.18 | 流通A股 | 4.82% | 减持 | 2023-09-30 | ||
| 6 | 药明康德603259历史分时日K | 15300 | 流通A股 | 5.15% | 增持 | 2023-08-28 | |||
| 7 | 药明康德603259历史分时日K | 15292.36 | 62.31 | 流通A股 | 5.15% | 减持 | 2023-06-30 | ||
| 8 | 药明康德603259历史分时日K | 16171.83 | 79.50 | 流通A股 | 5.45% | 减持 | 2023-03-31 | ||
| 9 | 药明康德603259历史分时日K | 17664.35 | 81.00 | 流通A股 | 5.97% | 减持 | 2022-12-31 | ||
| 10 | 药明康德603259历史分时日K | 18305.89 | 71.69 | 流通A股 | 6.18% | 减持 | 2022-09-30 | ||
| 11 | 药明康德603259历史分时日K | 19051.20 | 103.99 | 6.44% | 未变 | 2022-06-30 | |||
| 12 | 药明康德603259历史分时日K | 19051.2 | 112.38 | 流通A股 | 6.45% | 未变 | 2022-03-31 | ||
| 13 | 药明康德603259历史分时日K | 19051.2 | 118.58 | 流通A股 | 6.45% | 未变 | 2021-12-31 | ||
| 14 | 药明康德603259历史分时日K | 19051.20 | 152.80 | 流通A股 | 6.45% | 未变 | 2021-09-30 | ||
| 15 | 药明康德603259历史分时日K | 19051.20 | 156.59 | 6.46% | 增持 | 2021-06-30 | |||
| 16 | 药明康德603259历史分时日K | 15876 | 116.53 | 限售流通A股 | 6.48% | 未变 | 2021-03-31 | ||
| 17 | 药明康德603259历史分时日K | 15876.00 | 6.5% | 未变 | 2020-12-31 | ||||
| 18 | 药明康德603259历史分时日K | 15876.00 | 限售流通股 | 6.5% | 未变 | 2020-09-30 | |||
| 19 | 药明康德603259历史分时日K | 15876.00 | 6.5% | 未变 | 2020-09-23 | ||||
| 20 | 药明康德603259历史分时日K | 15876 | 限售流通股 | 0% | 未变 | 2020-08-31 | |||
| 21 | 药明康德603259历史分时日K | 15876.00 | 6.87% | 增持 | 2020-06-30 | ||||
| 22 | 药明康德603259历史分时日K | 11340.00 | 6.87% | 未变 | 2020-03-31 | ||||
| 23 | 药明康德603259历史分时日K | 11340.00 | 6.87% | 未变 | 2019-12-31 | ||||
| 24 | 药明康德603259历史分时日K | 11340.00 | 6.92% | 增持 | 2019-09-30 | ||||
| 25 | 药明康德603259历史分时日K | 8100.00 | 6.92% | 未变 | 2019-06-30 | ||||
| 26 | 药明康德603259历史分时日K | 8100.00 | 限售流通股 | 6.92% | 未变 | 2019-03-31 | |||
| 27 | 药明康德603259历史分时日K | 8100.00 | 限售流通股 | 6.95% | 未变 | 2018-12-31 | |||
| 28 | 药明康德603259历史分时日K | 8100 | 流通受限股份 | 7.77% | 未变 | 2018-09-30 | |||
| 29 | 药明康德603259历史分时日K | 8100 | 流通受限股份 | 7.77% | 未变 | 2018-06-30 | |||
| 30 | 药明康德603259历史分时日K | 8100 | 流通受限股份 | 7.774% | 未变 | 2018-05-07 | |||
| 31 | 药明康德603259历史分时日K | 8100 | 限售流通股 | 0% | 未变 | 2018-04-24 | |||
| 32 | 药明康德603259历史分时日K | 8100 | 境外法人股 | 8.638% | 新进 | 2018-04-16 |
g&c vi limited解禁股票 · · · · · ·
| 股票 | 解禁数量(万股) | 限售股类型 | 其他承诺描述 | 总市值 | 解禁日期 |
| 药明康德603259历史分时日K | 15876 | 首发原股东持股 | 亿 | 2021-05-10 | |
| 药明康德603259历史分时日K | 8100 | 首发原股东持股 | 亿 | 2021-05-08 |
热搜牛散
热门股票